OncoPan®: An NGS-Based Screening Methodology to Identify Molecular Markers for Therapy and Risk Assessment in Pancreatic Ductal Adenocarcinoma
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.
Details